[18F]DPA-714 PET显像显示短暂局灶性缺血后静脉给予骨髓基质细胞的免疫调节作用
研究在大鼠短暂性大脑中动脉闭塞模型缺血后3小时静脉给予骨髓基质细胞(BMSC)或溶媒,用[18F]DPA-714 PET在造模后3天和10天评估神经炎症。BMSC组神经功能缺损、体重下降和梗死体积均改善,脾和胸腺萎缩受抑制,10天时缺血区SUV升高被显著抑制,组织学显示淋巴器官和脑内炎症反应受抑制。作者认为[18F]DPA-714 PET/CT可准确显示脑炎症并评估BMSC疗效。
要点
- 大鼠短暂性大脑中动脉闭塞后3小时静脉给予BMSC可改善神经功能缺损、体重下降和梗死体积。
- 造模后3天两组[18F]DPA-714 PET均显示缺血区周围高SUV,10天时两组SUV进一步升高但BMSC组升高被显著抑制。
- 组织学显示BMSC组淋巴器官和脑内炎症反应受抑制,作者认为[18F]DPA-714 PET/CT可用于评估BMSC疗效。
核心结论
- 作者认为BMSC治疗可能通过调节全身炎症反应对缺血性卒中有效,[18F]DPA-714 PET/CT可准确显示脑炎症并在影像学上评估BMSC疗效,具有较大临床应用潜力。
研究设计与样本
- 大鼠短暂性大脑中动脉闭塞(MCAO)模型,缺血后3小时静脉给予BMSC或溶媒,分析神经功能缺损、体重、梗死体积和组织学,并在MCAO后3天和10天行[18F]DPA-714 PET。
主要发现
- MCAO后大鼠出现严重神经功能缺损和体重下降,细胞给药改善了这些表现及梗死体积。
- 脾和胸腺发生萎缩,细胞给药抑制了该萎缩。
- 溶媒组和BMSC组在MCAO后3天[18F]DPA-714 PET均显示缺血区周围高标准化摄取值(SUV)。
- MCAO后10天两组SUV均进一步升高,但BMSC组的升高被显著抑制。
- 组织学分析显示MCAO后淋巴器官和脑内发生炎症反应,BMSC组该反应受抑制。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The potential application of bone marrow stromal cell (BMSC) therapy in stroke has been anticipated due to its immunomodulatory effects. Recently, positron emission tomography (PET) with [18F]DPA-714, a translocator protein (TSPO) ligand, has become available for use as a neural inflammatory indicator. We aimed to evaluate the effects of BMSC administration after transient middle cerebral artery occlusion (MCAO) using [18F]DPA-714 PET. The BMSCs or vehicle were administered intravenously to rat MCAO models at 3 h after the insult. Neurological deficits, body weight, infarct volume, and histology were analyzed. [18F]DPA-714 PET was performed 3 and 10 days after MCAO. RESULTS: Rats had severe neurological deficits and body weight loss after MCAO. Cell administration ameliorated these effects as well as the infarct volume. Although weight loss occurred in the spleen and thymus, cell administration suppressed it. In both vehicle and BMSC groups, [18F]DPA-714 PET showed a high standardized uptake value (SUV) around the ischemic area 3 days after MCAO. Although SUV was increased further 10 days after MCAO in both groups, the increase was inhibited in the BMSC group, significantly. Histological analysis showed that an inflammatory reaction occurred in the lymphoid organs and brain after MCAO, which was suppressed in the BMSC group. CONCLUSIONS: The present results suggest that BMSC therapy could be effective in ischemic stroke due to modulation of systemic inflammatory responses. The [18F]DPA-714 PET/CT system can accurately demonstrate brain inflammation and evaluate the BMSC therapeutic effect in an imaging context. It has great potential for clinical application.
引用
- Tan C, Zhao S, Higashikawa K, et al. [18F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia. EJNMMI Res. 2018. PMID: 29717383. doi:10.1186/s13550-018-0392-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。